Breast cancer in young women: clinical decision-making in the face of uncertainty

Oncology (Williston Park). 2009 May;23(6):474, 477.

Authors

Kathryn J Ruddy¹, Ann H Partridge

Affiliation

¹ Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

PMID: 19544686

No abstract available

Publication types

Comment

MeSH terms

Adult
Age Factors
Breast Neoplasms / genetics
Breast Neoplasms / metabolism
Breast Neoplasms / therapy*
Cytochrome P-450 CYP2D6 / genetics
Decision Making*
Female
Fertility
Genetic Testing
Genotype
Humans
Ovary / drug effects
Premenopause
Receptor, ErbB-2 / metabolism
Selective Estrogen Receptor Modulators / therapeutic use
Tamoxifen / therapeutic use

Substances

Selective Estrogen Receptor Modulators
Tamoxifen
Cytochrome P-450 CYP2D6
Receptor, ErbB-2